Swiss regulator approves Roche-Regeneron Covid-19 drug
The Swiss medicines agency, Swissmedic, has given the green light to the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron for use in the treatment and prevention of Covid-19.
Ronapreve, a combination of two monoclonal antibodies (casirivimab and imdevimab), is approved for patients 12 years and up when “oxygen therapy or hospitalisation is not required and there is a high risk of developing a severe form of Covid-19,” Swissmedic said in a statementExternal link.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses.
The treatment can also be taken prophylactically when the immune response to Covid-19 vaccination is not adequate. It is the first drug authorised by the Swiss regulator for the prevention of Covid-19 in cases where there is not a sufficient immune response after vaccination due to other diseases or treatments.
Ronapreve is given as a single infusion into a vein or by injection under the skin. The application for the authorisation of the drug, submitted on March 5, didn’t include data on the efficacy of the drug against the Omicron variant.
Since-April, Ronapreve could be administered under the exceptions allowed in the Covid-19 Ordinance 3; an ordinance published by the Federal Council in June 2020 to combat the pandemic. This includes a list of products that can be placed on the market before the authorisation procedure is concluded.
The antibody cocktail has been authorised in several other locations including in Japan and the European Union. It has a conditional approval in the UK and Australia and is available for emergency use in the United States.
More orders
The Federal Office of Public Health (FOPH) has been building up its Covid-19 treatment reserves. On Monday, the FOPH announced that it had signed two additional contracts for more doses of both Ronapreve (4,000 doses) and the monoclonal drug sotrovimab (2,000 doses) developed by GlaxoSmithKline and Vir Biotechnology. The antibody for the latter was discovered by Swiss company Humabs BioMed.
This is on top of the 3,000 doses of each drug the government ordered earlier this year. Contract amounts are confidential for both drugs, according to the FOPH.
Popular Stories
More
Swiss Politics
In Switzerland, New Year brings ‘burka ban’ and pension hikes
Have you heard something about Swiss diplomacy that you’d like us to fact check?
Not all information circulating about Switzerland’s foreign relations is accurate or well understood. Tell us what you'd like us to fact check or clarify.
EU cuts aid to Hungary, Switzerland continues to pay
This content was published on
Earlier this year, the European Commission withdrew planned EU aid to Hungary because of violations of the rule of law. Switzerland shares the EU's doubts, but continues to pay its cohesion contribution to Hungary.
‘One million stars’ against poverty light up Swiss parliament square
This content was published on
Swiss charity Caritas lit thousands of candles on parliament square in Bern on Saturday evening to mark the "A Million Stars" solidarity campaign, a reminder that many people in Switzerland still live in poverty.
This content was published on
The Eurovision Song Contest shows are in high demand, with the result that profiteers are hoping to make a quick franc by buying up lots of tickets.
Former Swiss finance minister slams report on Credit Suisse collapse
This content was published on
Former Swiss Finance Minister Ueli Maurer has criticised a parliamentary report on UBS's takeover of Credit Suisse, rejecting accusations that he hid the seriousness of the situation from the government.
This content was published on
Researchers in Zurich have developed an electricity-free dehumidifier. It is a building element that allows walls and ceilings to absorb moisture from the air and store it temporarily.
Swiss man found dead in Iranian prison had allegedly collected soil samples
This content was published on
The Swiss man who died in an Iranian prison is said to have secretly taken soil samples beforehand, according to Iranian media.
This content was published on
Hackers have attacked the Swiss federal administration. Among other things, telephones, email and various federal websites and specialist applications were affected.
More and more Swiss celebrities and institutions leaving X
This content was published on
The short messaging service X has also lost its reputation in Switzerland. More and more personalities and institutions are turning their backs on tech billionaire Elon Musk's platform.
Swiss pharma reckons with its past, present and future
This content was published on
This is the story of how making drugs helped turn a small, mountainous country into an industry titan, and what the pandemic means for its future.
This content was published on
Swiss biopharma firm Roche has been granted emergency authorisation by US authorities to sell its at-home rapid Covid-19 test starting in January.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.